Trials / Completed
CompletedNCT03519672
Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the psychometric properties of a recently developed congenital thrombotic thrombocytopenic purpura (cTTP)-specific patient-reported outcomes (PRO) instrument.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | This is a non-interventional study. |
Timeline
- Start date
- 2018-07-12
- Primary completion
- 2019-04-08
- Completion
- 2019-04-08
- First posted
- 2018-05-09
- Last updated
- 2021-03-17
Locations
4 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT03519672. Inclusion in this directory is not an endorsement.